I live in New Zealand, which has a centralised purchasing agency for pharmaceuticals (called Pharmac). The TPP doesn&#x27;t require New Zealand to disband Pharmac. It can still negotiate reduced prices on behalf of the Kiwi public. The only change is that there is a more rigorous feedback and appeal process, which seems perfectly reasonable to me.